{"entity":{"type":"insider","cik":"0001594774","url":"/insider/0001594774","json_url":"/insider/0001594774.json","name":"Stuart Nancy","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":10,"first":"2015-03-12","last":"2023-02-16","span_basis":"filed_date"},"name_variants":[{"name":"Stuart Nancy","source":"filing","n_filings":10,"first_seen":"2015-03-12","last_seen":"2023-02-16"}],"transactions":[{"id":8182695,"accession":"0001209191-23-009951","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-009951","line_url":"/filing/0001209191-23-009951#line-1","is_derivative":false,"issuer_cik":"0001367920","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001367920","owner_cik":"0001594774","owner_name":"Stuart Nancy","owner_display_name":"Stuart Nancy","owner_url":"/insider/0001594774","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6048.0,"shares_display":"6,048","price_per_share":8.33,"price_display":"8.33","price_state":"stated","total_value":50379.84,"total_display":"50,379.84","total_whole":"50,380","shares_owned_after":262596.0,"shares_owned_after_display":"262,596","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-15","filed_date":"2023-02-16","scope":"insider"},{"id":8461640,"accession":"0001209191-23-005622","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-005622","line_url":"/filing/0001209191-23-005622#line-1","is_derivative":false,"issuer_cik":"0001367920","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001367920","owner_cik":"0001594774","owner_name":"Stuart Nancy","owner_display_name":"Stuart Nancy","owner_url":"/insider/0001594774","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13200.0,"shares_display":"13,200","price_per_share":8.35,"price_display":"8.35","price_state":"stated","total_value":110220.0,"total_display":"110,220.00","total_whole":"110,220","shares_owned_after":268644.0,"shares_owned_after_display":"268,644","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-30","filed_date":"2023-01-31","scope":"insider"},{"id":8605238,"accession":"0001209191-23-002554","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-002554","line_url":"/filing/0001209191-23-002554#line-1","is_derivative":false,"issuer_cik":"0001367920","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001367920","owner_cik":"0001594774","owner_name":"Stuart Nancy","owner_display_name":"Stuart Nancy","owner_url":"/insider/0001594774","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2893.0,"shares_display":"2,893","price_per_share":7.25,"price_display":"7.25","price_state":"stated","total_value":20974.25,"total_display":"20,974.25","total_whole":"20,974","shares_owned_after":281844.0,"shares_owned_after_display":"281,844","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-06","filed_date":"2023-01-09","scope":"insider"},{"id":6777422,"accession":"0001209191-22-010074","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-010074","line_url":"/filing/0001209191-22-010074#line-1","is_derivative":false,"issuer_cik":"0001367920","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001367920","owner_cik":"0001594774","owner_name":"Stuart Nancy","owner_display_name":"Stuart Nancy","owner_url":"/insider/0001594774","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6049.0,"shares_display":"6,049","price_per_share":3.08,"price_display":"3.08","price_state":"stated","total_value":18630.92,"total_display":"18,630.92","total_whole":"18,631","shares_owned_after":284737.0,"shares_owned_after_display":"284,737","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-14","filed_date":"2022-02-16","scope":"insider"},{"id":6367452,"accession":"0001209191-22-002404","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-002404","line_url":"/filing/0001209191-22-002404#line-1","is_derivative":false,"issuer_cik":"0001367920","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001367920","owner_cik":"0001594774","owner_name":"Stuart Nancy","owner_display_name":"Stuart Nancy","owner_url":"/insider/0001594774","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2894.0,"shares_display":"2,894","price_per_share":3.19,"price_display":"3.19","price_state":"stated","total_value":9231.86,"total_display":"9,231.86","total_whole":"9,232","shares_owned_after":170386.0,"shares_owned_after_display":"170,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-05","filed_date":"2022-01-07","scope":"insider"},{"id":4362583,"accession":"0001209191-21-011620","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-011620","line_url":"/filing/0001209191-21-011620#line-1","is_derivative":false,"issuer_cik":"0001367920","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001367920","owner_cik":"0001594774","owner_name":"Stuart Nancy","owner_display_name":"Stuart Nancy","owner_url":"/insider/0001594774","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6049.0,"shares_display":"6,049","price_per_share":7.32,"price_display":"7.32","price_state":"stated","total_value":44278.68,"total_display":"44,278.68","total_whole":"44,279","shares_owned_after":173280.0,"shares_owned_after_display":"173,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-17","scope":"insider"},{"id":2544972,"accession":"0001209191-20-038683","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-038683","line_url":"/filing/0001209191-20-038683#line-2","is_derivative":false,"issuer_cik":"0001367920","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001367920","owner_cik":"0001594774","owner_name":"Stuart Nancy","owner_display_name":"Stuart Nancy","owner_url":"/insider/0001594774","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10295.0,"shares_display":"10,295","price_per_share":11.335,"price_display":"11.34","price_state":"stated","total_value":116693.825,"total_display":"116,693.82","total_whole":"116,694","shares_owned_after":157629.0,"shares_owned_after_display":"157,629","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-22","filed_date":"2020-06-24","scope":"insider"},{"id":6605601,"accession":"0001209191-18-042304","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-042304","line_url":"/filing/0001209191-18-042304#line-2","is_derivative":false,"issuer_cik":"0001367920","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001367920","owner_cik":"0001594774","owner_name":"Stuart Nancy","owner_display_name":"Stuart Nancy","owner_url":"/insider/0001594774","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26127.0,"shares_display":"26,127","price_per_share":17.9392,"price_display":"17.94","price_state":"stated","total_value":468697.4784,"total_display":"468,697.48","total_whole":"468,697","shares_owned_after":89958.0,"shares_owned_after_display":"89,958","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-10","filed_date":"2018-07-11","scope":"insider"},{"id":6605598,"accession":"0001209191-18-042304","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-042304","line_url":"/filing/0001209191-18-042304#line-1","is_derivative":false,"issuer_cik":"0001367920","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001367920","owner_cik":"0001594774","owner_name":"Stuart Nancy","owner_display_name":"Stuart Nancy","owner_url":"/insider/0001594774","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5291.0,"shares_display":"5,291","price_per_share":17.5562,"price_display":"17.56","price_state":"stated","total_value":92889.8542,"total_display":"92,889.85","total_whole":"92,890","shares_owned_after":116085.0,"shares_owned_after_display":"116,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-09","filed_date":"2018-07-11","scope":"insider"},{"id":8849254,"accession":"0001209191-15-078178","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-078178","line_url":"/filing/0001209191-15-078178#line-2","is_derivative":false,"issuer_cik":"0001367920","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001367920","owner_cik":"0001594774","owner_name":"Stuart Nancy","owner_display_name":"Stuart Nancy","owner_url":"/insider/0001594774","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23216.0,"shares_display":"23,216","price_per_share":24.2944,"price_display":"24.29","price_state":"stated","total_value":564018.7904,"total_display":"564,018.79","total_whole":"564,019","shares_owned_after":25004.0,"shares_owned_after_display":"25,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-02","filed_date":"2015-11-03","scope":"insider"},{"id":8865259,"accession":"0001209191-15-025619","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-025619","line_url":"/filing/0001209191-15-025619#line-2","is_derivative":false,"issuer_cik":"0001367920","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001367920","owner_cik":"0001594774","owner_name":"Stuart Nancy","owner_display_name":"Stuart Nancy","owner_url":"/insider/0001594774","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46430.0,"shares_display":"46,430","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":696450.0,"total_display":"696,450.00","total_whole":"696,450","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-11","filed_date":"2015-03-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001367920","name":"CONCERT PHARMACEUTICALS, INC.","url":"/issuer/0001367920","role":"Officer (Chief Operating Officer)","n_filings":10,"first_seen":"2015-03-12","last_seen":"2023-02-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001594774","retrieved_at":"2026-08-24T07:14:27+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}